Estimating disease severity of Omicron and Delta SARS-CoV-2 infections COMMENT

被引：140

作者：

Sigal, Alex ^{[1
,2
,3
,4
]}

Milo, Ron ^{[5
]}

Jassat, Waasila ^{[6
,7
]}

机构：

[1] Africa Hlth Res Inst, Durban, South Africa

[2] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa

[3] Max Planck Inst Infect Biol, Berlin, Germany

[4] Ctr AIDS Programme Res South Africa, Durban, South Africa

[5] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel

[6] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa

[7] Right Care, Centurion, South Africa

来源：

NATURE REVIEWS IMMUNOLOGY | 2022年 / 22卷 / 05期

关键词：

D O I：

10.1038/s41577-022-00720-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The Omicron variant of SARS-CoV-2 has been reported to cause milder disease in adults but lead to increased hospital admissions in children. How can we compare disease severity in Omicron and Delta infections, and how should differences be interpreted?

引用

页码：267 / 269

页数：3

共 50 条

[21] Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity
Mwendwa, Fridah
Kanji, Akbar
Bukhari, Ali Raza
Khan, Unab
Sadiqa, Ayesha
Mushtaq, Zain
Nasir, Nosheen
Mahmood, Syed Faisal
Aamir, Uzma Bashir
Hasan, Zahra
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (06) : 1100 - 1107
[22] The mysterious origins of the Omicron variant of SARS-CoV-2 Comment
Du, Pei
Gao, George Fu
Wang, Qihui
INNOVATION, 2022, 3 (02):
[23] Delta and Omicron SARS-CoV-2 Outcomes in Vaccinated Individuals With Chronic Lung Disease
Daungsupawong, Hineptch
Wiwanitkit, Viroj
CHEST, 2024, 166 (05) : e167 - e167
[24] Antibody titers and breakthrough infections with Omicron SARS-CoV-2
Dimeglio, Chloe
Migueres, Marion
Mansuy, Jean-Michel
Saivin, Sylvie
Miedouge, Marcel
Chapuy-Regaud, Sabine
Izopet, Jacques
JOURNAL OF INFECTION, 2022, 84 (04) : E13 - E15
[25] Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants
Esper, Frank P.
Adhikari, Thamali M.
Tu, Zheng Jin
Cheng, Yu Wei
El-Haddad, Kim
Farkas, Daniel H.
Bosler, David
Rhoads, Daniel
Procop, Gary W.
Ko, Jennifer S.
Jehi, Lara
Li, Jing
Rubin, Brian P.
JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (03): : 344 - 352
[26] Differences in virus and immune dynamics for SARS-CoV-2 Delta and Omicron infections by age and vaccination histories
Tan, Maxine W.
Anelone, Anet J. N.
Tay, An Ting
Tan, Ren Ying
Zeng, Kangwei
Tan, Kelvin Bryan
Clapham, Hannah Eleanor
BMC INFECTIOUS DISEASES, 2024, 24 (01)
[27] SARS-CoV-2 Genomic Surveillance Enables the Identification of Delta/Omicron Co-Infections in Argentina
Pisano, Maria Belen
Sicilia, Paola
Zeballos, Maximiliano
Lucca, Andrea
Fernandez, Franco
Castro, Gonzalo M.
Goya, Stephanie
Viegas, Mariana
Lopez, Laura
Barbas, Maria Gabriela
Re, Viviana E.
FRONTIERS IN VIROLOGY, 2022, 2
[28] Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China
Li, Qinggang
Liu, Xiaorui
Li, Lei
Hu, Xiaobo
Cui, Guangying
Sun, Ranran
Zhang, Donghua
Li, Juan
Li, Yonghong
Zhang, Yong
Shen, Shen
He, Ping
Li, Shasha
Liu, Yanmin
Yu, Zujiang
Ren, Zhigang
FRONTIERS IN MEDICINE, 2022, 9
[29] Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
Martinez-Gonzalez, Brenda
Vazquez-Sirvent, Lucia
Soria, Maria E.
Minguez, Pablo
Salar-Vidal, Llanos
Garcia-Crespo, Carlos
Gallego, Isabel
de Avila, Ana, I
Llorens, Carlos
Soriano, Beatriz
Ramos-Ruiz, Ricardo
Esteban, Jaime
Fernandez-Roblas, Ricardo
Gadea, Ignacio
Ayuso, Carmen
Ruiz-Hornillos, Javier
Perez-Jorge, Concepcion
Domingo, Esteban
Perales, Celia
JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (09):
[30] Vaccine effectiveness against delta and omicron variants of SARS-CoV-2
Kundi, Michael
BMJ-BRITISH MEDICAL JOURNAL, 2023, 381

← 1 2 3 4 5 →